Others titles

  • HIV in the United States
  • HIV Geographic Distribution
  • HIV/AIDS National Statistics

Keywords

  • HIV
  • AIDS
  • HIV/AIDS
  • Infectious diseases
  • STD
  • Sexually Transmitted Disease
  • HIV Diagnose
  • HIV Stages
  • Living with HIV
  • HIV deaths

US State Level HIV Cases

This dataset contains surveillance data on diagnoses of HIV for the United States in estimates rates and numbers for Human Immunodeficiency Virus (HIV) infection diagnosis and stage 3 infection Acquired Immunodeficiency Syndrome (AIDS) as collected by the Centers for Disease Control and Prevention (CDC).

Log in to download
Complexity

Get The Data

For getting access to data download links please read and accept the end-user license agreement.
Your Data License
  • Research
    Non-Commercial, Share-Alike, Attribution Free Forever
  • Commercial
    Commercial Use, Remix & Adapt, White Label Log in to download

John Snow Labs Standard End User License Agreement

Last updated:January 20, 2021

This Standard End User License Agreement (“EULA”) applies to customers of John Snow Labs Inc. (as defined below), using any product of John Snow Labs Inc. on John Snow Labs Marketplace as defined below (hereinafter referred to “you”) and John Snow Labs Inc., a Delaware corporation (“John Snow Labs”, “we” or “us”).

By downloading, installing, and/or using (as applicable) any Product of John Snow Labs (as defined below), you automatically agree to be bound by, and use our Products in compliance with, this EULA. This EULA, together with additional terms and conditions and/or policies referenced herein or located on https://www.johnsnowlabs.com and/or conveyed to you by John Snow Labs, is a legally binding contract between you and John Snow Labs.

PLEASE READ THIS EULA CAREFULLY BEFORE PURCHASING, INSTALLING OR USING OUR PRODUCTS MADE AVAILABLE ON JOHN SNOW LABS MARKETPLACE.

We may make changes to this EULA from time to time. When we do so, we will revise the “last updated” date given above. The then-current version of this EULA will supersede all earlier versions. You agree that your continued use of our Products after such changes have been published to our EULA will constitute your acceptance of such revised EULA.

Definitions

“John Snow Labs Data Library” means a data library located at https://www.johnsnowlabs.com;

“Products” means products and services of John Snow Labs that you download and use from listings in John Snow Labs Data Library;

Important Notice

By installing and using our Products, you acknowledge that the use of the Products can be subject to the restrictions and controls imposed by United States export regulations.

You represent and warrant that you do not intend to use the Products for any purpose prohibited by United States export regulations, including, without limitation, terrorism, cyber-attacks, cyber-crimes, money-laundering, industrial espionage, or nuclear, chemical or biological weapons proliferation. Further, you represent and warrant that you are not listed as a denied party on any list governing United States exports.

Eligibility

Our Products can be used by an individual, business or other legal entity, or both. If you are entering into this EULA, or using the Products, on behalf of a company or other legal entity, you represent that you have the authority to bind such entity to this EULA, in which case “you” shall refer to such entity.

In the event you have entered into a separate written agreement with John Snow Labs regarding the Products that contemplates terms that are inconsistent with this EULA, the written agreement shall control and this EULA will not apply to you to the extent inconsistent with such written agreement, or, if such written agreement is contemplated to be in lieu of this EULA, then this EULA shall not apply at all.

Your Access and Use

Subject to your compliance with this EULA, as well as any other applicable policies, John Snow Labs grants you non-exclusive, non-transferable, license to install, access to, modify, and use of, the Products worldwide (subject to applicable export laws) during the term of this EULA (as described below) solely for research, private study and personal use of Products.

This license is personal to you, and you may not resell our Products, permit other users access to our Products through your account. Your right to use our Products is limited by all terms and conditions set forth in this EULA.

Except for your pre-existing rights and this license granted to you, we and our licensors retain all rights, titles and interests in and to our Products, all related intellectual property rights, including trademarks (whether registered or pending), domain and business names. Our Products are protected by applicable intellectual property laws, including United States copyright law and international treaties.

Except for the foregoing license, you have no other rights in the Products and you may not modify, edit, copy, reproduce, create derivative works of, reverse engineer, alter, enhance or in any way exploit the Products in any manner. If you breach any of this EULA, the above license will terminate automatically.

You will be deemed to have taken any action that you permit, assist or facilitate any person or entity to take related to this EULA, your content or use of the Products. You are responsible for end users’ use of your content and the Products. You will ensure that all end users comply with your obligations under this EULA and that the terms of your agreement with each end user are consistent with this EULA. If you become aware of any violation of your obligations under this EULA caused by an end user, you will immediately suspend access to your content and the Products by such end user. We do not provide any support or services to end users unless we have a separate agreement with you or an end user obligating us to provide such support or services.

Restrictions

You will access or use our Products solely via John Snow Labs Data Library.

Except as otherwise explicitly provided in this EULA or as may be expressly permitted by applicable law, you will not, and will not permit or authorize any third party to:

  1. reproduce, modify, translate, enhance, decompile, disassemble, reverse engineer or create derivative works of any of our Products or its technological features or measures;
  2. rent, lease, sell, resell, loan, distribute, or sublicense access to any of our Products;
  3. circumvent or disable any security or technological features or measures of our Products;
  4. use our intellectual property rights without our express prior written authorization;
  5. use our Products for more than one trial period, unless the trial period is extended by John Snow Labs’ prior written permit;
  6. use our Products with an intent to build a competitive product or service, or copy or substantially copy any ideas, features, functions, organization, structure, application program interface, graphics, or user interface of the Products;
  7. store, copy, modify, distribute, or resell any of the information; audio, visual, and audiovisual works, or other content made available on our Products (collectively, “Content”) or compile or collect any Content as part of a database or other work;
  8. use any automated tool (e.g., robots, spiders) to access or use our Products, or to store, copy, modify, distribute, or resell any Content;
  9. circumvent or disable any rights management, usage rules, or other security features of our Products;
  10. use our Products in a manner that overburdens, or that threatens the integrity, performance, or availability of, our Products; or
  11. remove, alter, or obscure any proprietary notices (including copyright and trademark notices) on any portion of our Products or any Content.

Fees and Taxes

Your use of the Products is subject to our fees. All fees are given on our website https://www.johnsnowlabs.com. Except as set forth in this EULA, the fees are non-refundable. We are entitled to revise our fees from time to time.

The fees exclude any federal, state or local taxes, VAT, GST, or similar taxes. You are responsible for identification and payment of all taxes as required by applicable law.

Term and Termination

This EULA will become effective as of the date of your order of Products and shall be in effect until terminated.

John Snow Labs may suspend or terminate your right to use our Products, if you or your end user’s use of the Products:

  1. is in breach of this EULA;
  2. poses a security risk to our Products;
  3. could adversely impact our systems, the Products or other customers;
  4. could subject us, our affiliates, or any third party to liability; or
  5. could be fraudulent.

We may also suspend or terminate your right to use our Products, if you fail to perform your payment obligations, or you have ceased to operate in the ordinary course, made an assignment for the benefit of creditors or similar disposition of your assets, or become the subject of any bankruptcy, reorganization, liquidation, dissolution or similar proceeding.

We may also suspend or terminate your right to use our Products without any reason upon a relevant 30 days’ written notice to you and will refund the unused fees pre-paid by you for access to the Products for the affected time period (if any). Where your access is suspended or terminated by the breach of this EULA or applicable laws, John Snow Labs will will not provide, or be liable for, any refund.

You will cease use of the Products during any period of suspension, or upon termination of this EULA.

All provisions which by their nature are intended to survive termination shall survive termination of this EULA.

Support

If applicable to your Product, John Snow Labs will provide you with the support services. If you use a trial access, support services are excluded. Under this EULA, our support services exclude any installation, training, maintenance services (including any error corrections, bug fixes, or new releases), technical assistance, consulting services, or other services of any kind. Such services are provided at John Snow Labs’ discretion.

From time to time John Snow Labs can perform updates to our software. If available, such updates may include bug fixes, new features and/or enhancements. You are solely responsible for deploying such updates at your own risk and liability.

Access to our Products

We do not provide you with the equipment to access our Products. You are responsible for all fees charged by third parties related to your access and use of our Products (e.g., charges by Internet service providers).

You are responsible for monitoring your use of the Products, including payment of all fees and/or taxes related to such access and use. You agree that John Snow Labs is permitted to request and you hereby consent to provide John Snow Labs information related to your use of the Products for auditing purposes.

You also certify that you are legally permitted to use the Products, and take full responsibility for the selection and use of the Products. This EULA is void where prohibited by law, and the right to use the Products is revoked in such jurisdictions. John Snow Labs makes no claim that the Products may be lawfully used outside of the United States. If you use the Products from outside of the United States, you do so at your own risk and you are responsible for compliance with the laws of jurisdiction.

Privacy Policy

We may collect, store and receive personal and other information about you through our Products. Our collection and use of this information is governed by our Privacy Policy available at https://www.JohnSnowLabs.com/privacy/ which may be amended from time to time.

Links and Third Party Content

Our Products may display, or contain links to, third party products, services, and websites. Any opinions, advice, statements, services, offers, or other information that constitutes part of the content expressed, authored, or made available by other users or other third parties, or which is accessible through or may be located using our Products (collectively, “Third Party Content”) are those of the respective authors or producers and not of us or our shareholders, directors, officers, employees, agents, or representatives.

We do not control Third Party Content and do not guarantee the accuracy, integrity or quality of such Third Party Content. We are not responsible for the performance of, we do not endorse, and we are not responsible or liable for, any Third Party Content or any information or materials advertised in any Third Party Content. By using our Products, you may be exposed to content that is offensive, indecent, or objectionable. We are not responsible or liable, directly or indirectly, for any damage or loss caused to you by your use of or reliance on any goods, services, or information available on or through any third party service or Third Party Content. It is your responsibility to evaluate the information, opinion, advice, or other content available on and through our Products.

Proprietary Rights

John Snow Labs will not obtain any rights under this EULA from you (or your licensors) to your content.

The Products, including software, is and remains the exclusive property of John Snow Labs and its licensors. Except for the access and use rights expressly set forth in this EULA, no license or other rights in or to the Products or John Snow Labs trademark(s) and other intellectual property rights therein, are granted to you, and all such licenses and rights are expressly reserved. You will not remove, alter, or obscure any proprietary notices (including copyright and trademark notices) on any portion of our Products or any Content.

Trademarks

“John Snow Labs,” the John Snow Labs logo, and any other product, business or service name or slogan, whether registered or pending, displayed on our Products are trademarks of John Snow Labs, Inc. or its suppliers or licensors, and may not be copied, imitated or used, in whole or in part, without the prior written permission of John Snow Labs or the applicable trademark holder. You may not use any metatags or any other “hidden text” utilizing “John Snow Labs” or any other name, trademark or product, business or service name of John Snow Labs without our prior written permission. In addition, the look and feel of our Products, including all page headers, custom graphics, button icons and scripts, is the service mark, trademark and/or trade dress of John Snow Labs and may not be copied, imitated or used, in whole or in part, without our prior written permission. All other trademarks, pending trademarks, registered trademarks, product names and company names or logos mentioned in our Products are the property of John Snow Labs Inc. and/or their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, supplier, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by us.

Disclaimer of Warranties

YOUR USE OF THE PRODUCTS IS AT YOUR SOLE RISK. THE PRODUCTS AND CONTENT EACH ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS. WE AND OUR SUPPLIERS AND LICENSORS EXPRESSLY DISCLAIM ALL WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, AND NON-INFRINGEMENT. WE DO NOT GUARANTEE THE ACCURACY, COMPLETENESS, OR USEFULNESS OF THE PRODUCTS OR ANY CONTENT, AND YOU RELY ON THE PRODUCTS AND CONTENT AT YOUR OWN RISK. ANY MATERIAL THAT YOU ACCESS OR OBTAIN THROUGH OUR PRODUCTS IS DONE AT YOUR OWN DISCRETION AND RISK AND YOU WILL BE SOLELY RESPONSIBLE FOR ANY DAMAGE TO YOUR COMPUTER OR LOSS OF DATA THAT RESULTS FROM THE DOWNLOAD OF ANY MATERIAL THROUGH OUR PRODUCTS. NO ADVICE OR INFORMATION, WHETHER ORAL OR WRITTEN, OBTAINED BY YOU FROM US OR THROUGH OR FROM OUR PRODUCTS WILL CREATE ANY WARRANTY NOT EXPRESSLY STATED IN THIS EULA. SOME STATES MAY PROHIBIT A DISCLAIMER OF WARRANTIES AND YOU MAY HAVE OTHER RIGHTS THAT VARY FROM STATE TO STATE.

Limitation of Liability

WE AND OUR SUPPLIERS AND LICENSORS WILL NOT BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR EXEMPLARY DAMAGES, INCLUDING BUT NOT LIMITED TO, DAMAGES FOR LOSS OF PROFITS, GOODWILL, USE, DATA, OR OTHER INTANGIBLE LOSSES (EVEN IF WE HAVE BEEN ADVISED OF THE POSSIBILITY OF THESE DAMAGES), RESULTING FROM YOUR USE OF OUR PRODUCTS AND CONTENT. UNDER NO CIRCUMSTANCES WILL THE TOTAL LIABILITY OF US AND OUR SUPPLIERS AND LICENSORS OF ALL KINDS ARISING OUT OF OR RELATED TO YOUR USE OF THE PRODUCTS AND CONTENT (INCLUDING BUT NOT LIMITED TO WARRANTY CLAIMS), REGARDLESS OF THE FORUM AND REGARDLESS OF WHETHER ANY ACTION OR CLAIM IS BASED ON CONTRACT, TORT, OR OTHERWISE, EXCEED THE AMOUNTS, IF ANY, THAT YOU HAVE PAID FOR YOUR USE OF THE PRODUCTS AND CONTENT. BECAUSE SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, THE ABOVE LIMITATION MAY NOT APPLY TO YOU.

Indemnity

To the full extent permitted by applicable law, you shall defend, indemnify and hold harmless John Snow Labs, its affiliates and its licensors, and each of their respective employees, officers, directors, and representatives from and against any claims, damages, losses, liabilities, costs, and expenses (including reasonable attorney’s fees) arising out of or relating to any third party claim concerning: (a) your use of the Products; (b) breach of this EULA or violation of applicable law by you; (c) any content or the combination of such content with other software, content or processes, including any claim involving alleged infringement or misappropriation of third-party rights by such content or combination; or (d) breach of any obligation or duty you owe to a third party.

Legal Notices

Enforcement of this EULA will be governed by the laws of the State of Delaware, excluding its conflict and choice of law principles. The exclusive jurisdiction and venue for any claims arising out of or related to this EULA or your use of the Products will lie in the state and federal courts located in Sussex County, within the State of Delaware, and you irrevocably agree to submit to the jurisdiction of such courts. Our failure to enforce any right or provision in this EULA will not constitute a waiver of such right or provision unless acknowledged and agreed by us in writing. In the event that a court of competent jurisdiction finds any provision of this EULA to be illegal, invalid, or unenforceable, the remaining provisions will remain in full force and effect.

Notifications

We may use your contact information to notify you if we have any legitimate interest or if we need to notify you on any important information related to your use of Products. We will not send you newsletters unless you expressly consented to such notifications.

Contacting Us

If you have any questions or concerns about our Products or this EULA, you may contact us by email at support@JohnSnowLabs.com.

Description

Disease Control and Prevention (CDC) collects, analyzes, and disseminates surveillance data on diagnoses of HIV infection; these data are the national source of information on HIV in the United States. The data presented are estimated numbers and rates and are based on the date of diagnosis of HIV infection and infection classified as stage 3 (AIDS) (diagnosed through December 31, 2014; reported as of Aug 31, 2015). Estimated numbers resulted from statistical adjustment that accounted for reporting delays and missing transmission category (where appropriate), but not for incomplete reporting. For the assessment of trends in diagnoses, deaths, or prevalence, it is preferable to use statistically adjusted (estimated) data to eliminate artifacts of reporting in the surveillance system. Rates and trends based on estimated numbers less than 12 should be interpreted with caution because the estimates have relative standard errors greater than 30% and are considered unreliable. In addition, county level data should be interpreted with caution, as numbers for some counties may reflect current or past prison populations.

Surveillance of HIV Infection:
As of April 2008, 57 areas (50 states, the District of Columbia, and 6 U.S. dependent areas) had implemented confidential name-based HIV infection reporting. The Atlas includes data from case reports from 56 areas (50 states, the District of Columbia, American Samoa, Guam, the Northern Mariana Islands, Puerto Rico, and the U.S. Virgin Islands) in which laws or regulations require confidential reporting by name for adults and adolescents with confirmed diagnoses of HIV infection (including stage 3 (AIDS)) as of December 31, 2014. Data for the Republic of Palau are not currently included in the Atlas. After the removal of personal identifying information, data from these reports were submitted to CDC. Although AIDS cases have been reported to CDC since 1981, the implementation of HIV infection reporting has differed from state to state. All states, the District of Columbia, and 6 U.S. dependent areas had fully implemented name-based HIV infection reporting by April 2008. Data on diagnoses of HIV infection should be interpreted with caution. Data may not be representative of all persons with HIV because not all infected persons have been tested. Also, many states offer anonymous testing; the results of anonymous tests are not reported to the confidential name-based HIV registries of state and local health departments. The data presented in the Atlas provide minimum estimates of persons for whom HIV infection has been diagnosed and reported to the national HIV surveillance system. In addition, because surveillance practices differ, the reporting and the updating of a person’s clinical and vital status differ among states. The completeness of reporting of HIV diagnoses is estimated at more than 80. Due to the confidentiality of the HIV diagnosis reporting and the differences in surveillance practices, there is a minimum estimate provided of persons diagnosed with the infection. The death rates are also provided.

Deaths:
Persons reported to the national HIV surveillance system are assumed alive unless their deaths have been reported to CDC by state/local HIV surveillance programs. Death data include deaths of persons with diagnosed HIV infection or with infection classified as stage 3 (AIDS) regardless of the cause of death. Because of delays in the reporting of deaths, death data are displayed only through 2013 (HIV infection: 2008 -2013; stage 3 (AIDS): 2000-2013). The exclusion of data for the most recent year allowed at least 18 months for deaths to be reported to CDC. The estimated numbers and rates of deaths resulted from statistical adjustment for delays in reporting.
Persons Living with a Diagnosed HIV Infection or infection classified as stage 3 (AIDS)

Because of delays in the reporting of deaths, prevalence data are only displayed through 2013. The data reflect persons living with diagnosed HIV infection at the end of each year during 2008-2013, or persons living with infection ever classified as stage 3 (AIDS) at the end of each year during 2000-2013. The exclusion of data for the most recent year allowed at least 18 months for deaths to be reported to CDC and for these deaths to be factored into prevalence calculations.

Diagnoses: Diagnoses of HIV infection or infection classified as stage 3 (AIDS) refer to confirmed diagnoses during a given time period. For example, the 2014 data on HIV infection would include persons with laboratory-confirmatory evidence of HIV infection during January 1, 2014 through December 31, 2014 and reported to CDC through July 31, 2015.

Cell suppression:
Current data re-release agreements between CDC and state/local HIV surveillance programs require certain levels of cell suppression at the state and county level in order to ensure confidentiality of personal identifying information.

State level:
A data suppression rule is applied to 1-way and 2-way demographic/transmission category data where the population denominator is less than 100. In addition, data are suppressed or aggregated to preclude arithmetic calculation of a suppressed cell: two-way demographic/transmission category stratifications for dependent areas (except Puerto Rico, for age and sex), as well as the race groups Native Hawaiians or other Pacific Islanders (NHOPIs) and Multiple races, are not displayed. Two-way demographic/transmission category stratifications are not shown for New Hampshire.

County level:
In addition to adhering to the county-level data suppression requirements of the data re-release agreements for each state, additional data suppression rules were applied. For county totals, a data suppression rule was applied where the population denominator is less than 100 or total case count less than 5. Additional suppression rules were applied to 1-way demographic/transmission category data to preclude arithmetic calculation of a suppressed cell. National data displayed in the Atlas may not be comparable to surveillance data published by individual jurisdictions. This is because: (1) CDC de-duplicates cases at the national level, and (2) national data are statistically adjusted for reporting delays and missing transmission category, but not for incomplete reporting.

Age groups:
As mentioned above, the Atlas only includes data for adults and adolescents (i.e., persons aged 13 and older). When comparing HIV data with STD and/or TB data, the HIV age group remains ages 13-24.

Race/ethnicity:
In 1997, the Office of Management and Budget (OMB) announced the revisions to the classification of federal data on race and ethnicity. Starting with 2003, the HIV surveillance data presented utilize this new classification standard and the following racial/ethnic categories: American Indian or Alaska Native, Asian, black or African American, Hispanic or Latino, Native Hawaiian or Other Pacific Islander, white and multiple races. (As that format was not available for data collected prior to 2003, data are not displayed for the years 2000 through 2002 for the race categories Asian, Native Hawaiian and other Pacific Islander, and multiple races). For data on persons living with HIV infection or persons living with infection ever classified as stage 3 (AIDS), the Asian category includes Asian/Pacific Islander legacy cases (cases that were diagnosed and reported under the pre-1997 OMB race/ethnicity classification system). Persons of Hispanic/Latino ethnicity can be of any race

Transmission category:
Transmission category is the term for the classification of cases that summarizes a person‚Äôs possible HIV risk factors; the summary classification results from selecting, from the presumed hierarchical order of probability, the one risk factor most likely to have resulted in HIV transmission. The exception is men who had sexual contact with other men and injected drugs; this group makes up a separate transmission category. Persons whose transmission category is classified as male-to-male sexual contact include men who report sexual contact with other men (i.e., homosexual contact) and men who report sexual contact with both men and women (i.e., bisexual contact). Persons whose transmission category is classified as injection drug use (IDU) are persons who injected non-prescribed drugs. Persons whose transmission category is classified as heterosexual contact are persons who have ever had specific heterosexual contact with a person known to have, or to be at high risk for, HIV infection (e.g., an injection drug user). All other transmission categories have been collapsed –other- into transmission category includes: hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified

Rates:
Rates per 100,000 population were calculated for (1) the numbers of diagnoses of HIV infection and the numbers of infections classified as stage 3 (AIDS), (2) the numbers of deaths of persons with diagnosed HIV infection and deaths of persons with infection classified as stage 3 (AIDS), and (3) the numbers of persons living with diagnosed HIV infection and persons living with infection classified as stage 3 (AIDS).The population denominators used to compute the rates for the 50 states, the District of Columbia, and Puerto Rico were based on the Vintage 2009 postcensal estimates file (for the years 2000 to 2009) and the Vintage 2014 file (for years 2010 to 2014) from the U.S. Census Bureau. The population denominators for American Samoa, Guam, the Northern Mariana Islands, and the U.S. Virgin Islands were based on estimates and projections from the U.S. Census Bureau’s International Data Base. Each rate was calculated by dividing the estimated total number of diagnoses (or deaths or prevalence) for the calendar year by the population for that calendar year and then multiplying the result by 100,000. The denominators used for calculating age-, sex-, and race/ethnicity-specific rates were computed by applying the appropriate vintage estimates for age, sex, and race/ethnicity for the 50 states and the District of Columbia. The same method was used to calculate the denominators for Puerto Rico, with the exception of race/ethnicity estimates; these data are not available for Puerto Rico. Because of lack of data from the U.S. Census Bureau and small cell sizes, subpopulation rates by age, sex, and race/ethnicity are not calculated for the dependent areas (except Puerto Rico). Similarly, rates for transmission categories are not provided because of the absence of denominator data (i.e., the denominator data used in this report come from the U.S. Census Bureau, but the bureau does not collect data on transmission categories.

Description source: Centers for disease control and prevention, C.D.C. (2016). Cdc.gov. Retrieved 24 September, 2016.

About this Dataset

Data Info

Date Created

2014

Last Modified

2022-11-03

Version

2022-11-03

Update Frequency

Biennial

Temporal Coverage

2017-2019

Spatial Coverage

United States of America

Source

John Snow Labs; Centers for Disease Control and Prevention;

Source License URL

Source License Requirements

N/A

Source Citation

N/A

Keywords

HIV, AIDS, HIV/AIDS, Infectious diseases, STD, Sexually Transmitted Disease, HIV Diagnose, HIV Stages, Living with HIV, HIV deaths

Other Titles

HIV in the United States, HIV Geographic Distribution, HIV/AIDS National Statistics

Data Fields

Name Description Type Constraints
IndicatorDisease Indicatorstring-
YearYear the data was collected.date-
StateStatestring-
RateRate of Indicatornumberlevel : Ratio
CasesNumber of casesnumberlevel : Ratio

Data Preview

IndicatorYearStateRateCases
Receipt of HIV medical care2019Alabama10325
Receipt of HIV medical care2018Alabama10037
Receipt of HIV medical care2017Alabama9395
PrEP coverage and number of persons prescribed2019Alabama1833
PrEP coverage and number of persons prescribed2018Alabama1535
PrEP coverage and number of persons prescribed2017Alabama1011
Linkage to HIV care2019Alabama505
Linkage to HIV care2018Alabama488
Linkage to HIV care2017Alabama499
Knowledge of Status2019Alabama13767